MedPath

Volume Expansion using a balanced gelatin solution in patients undergoing major abdominal surgery.

Phase 1
Conditions
Intravascular volume deficits in major abdominal surgery
MedDRA version: 9.1Level: PTClassification code 10021137Term: Hypovolaemia
Registration Number
EUCTR2008-005175-10-GB
Lead Sponsor
Guys and St Thomas' NHS Foudation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

- Patients undergoing major abdominal surgery in the Enhanced Recovery After Surgery programme at Guy’s and St Thomas’ NHS Foundation Trust

- ASA 1-3

- 18 years or over

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Known hypersensitivity to Gelofusine or Geloplasma
- Oliguric or anuric renal dysfunction requiring dialysis
- EGFR < 60 ml/min
- Myocardial infarction within the previous 3 weeks
- Heart failure (>NYHA 2)
- Liver insufficiency (aspartate aminotransferase >40 U litre–1, alanine aminotransferase >40 U litre–1)
- Absence of written, informed consent

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To determine whether there is any difference in acid-base or electrolyte status between patients resuscitated with a balanced gelatin solution or a conventional unbalanced gelatin solution. ;Secondary Objective: ;Primary end point(s): - Postoperative chloride levels<br>- Postoperative base excess
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath